Marilyn Norton MD in Chula Vista, California

Home California Chula Vista

Marilyn Norton MD has Hematology/oncology as her primary medical specialty. Their primary office is: 769 Medical Ctr Ct in Chula Vista, California. There is an additional office location, for a total of two, for Marilyn Norton MD that can be viewed further down.

They're a part of the: Marilyn S. Norton M.d., Inc. medical group which has around 2 members. You can call their office at 619-482-8430 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Loma Linda University School Of Medicine and graduated in 1989 (around 35 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Marilyn S Norton MD Office Phone and Directions

Marilyn Norton MD
Marilyn S. Norton M.d., Inc.
769 Medical Ctr Ct
Chula Vista, California 91911
619-482-8430

Patient Ratings
Please rate your experience with Marilyn Norton MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 619-482-8430

Enter a starting address:

Healthcare Info for Marilyn Norton MD

Medical School: Loma Linda University School Of Medicine
Graduation Year: 1989
The Primary Medical Specialty for Marilyn Norton MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 35
PAC (PECOS ID)#: 8729055967
NPI #: 1417060054
NPI Created On: 08/17/2006
NPI Last Updated Listed as: 07/20/2012
Primary Taxonomy Code: 207RH0003X
License Number:
G70444
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Tagalog, Spanish.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Hydration infusion into a vein 31 minutes to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, darbepoetin alfa, 1 microgram (non-esrd use)

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $33

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788209683

Being Disputed:: No

Product Related: No

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788209685

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788209687

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788209689

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013571

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013569

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $99

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013573

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013575

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795376553

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818585841

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Additional Office Locations

1. Emergency And Acute Care Medical Corporation
751 Medical Ctr Ct
Chula Vista, CA 91911
Group Members: 374

Phone: 619-482-8430

Enter a starting address:

Hematology/oncology Professionals in Chula Vista

1.
Ramesh Moolani

855 3rd Ave
Chula-vista, CA

2.
Ignacio Iturbe MD

855 3rd Ave
Chula-vista, CA

3.
Ignacio Iturbe MD

435 H St
Chula-vista, CA
On Call Specialists Medical Group Of San Diego Inc

4.
Philip Marjon

450 4th Ave
Chula-vista, CA
The Oncology Institute Ca, A Professional Corporation

5.
Anwer Shaikh MD

450 4th Ave
Chula-vista, CA
The Oncology Institute Ca, A Professional Corporation

6.
Mariela Macias

1400 E Palomar St
Chula-vista, CA
Sharp Rees-stealy Medical Group Inc

Providers in Marilyn S. Norton M.d., Inc.

1.Kenneth Johnson Md

769 Medical Ctr Ct
Chula Vista Ca 91911-6602
Marilyn S. Norton M.d., Inc.
Hematology

2.Marilyn Norton Md

769 Medical Ctr Ct
Chula Vista Ca 91911-6602
Marilyn S. Norton M.d., Inc.
Hematology/oncology

View all 2 members of Marilyn S. Norton M.d., Inc. medical group